Back
Dynavax Technologies 10K Form
Buy
63
DVAX
Dynavax Technologies
Last Price:
11.80
Seasonality Move:
12.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | DVAX/Dynavax Technologies Quarterly |
| 2023-11-02 | 10Q | DVAX/Dynavax Technologies Quarterly |
| 2023-08-03 | 10Q | DVAX/Dynavax Technologies Quarterly |
| 2023-05-02 | 10Q | DVAX/Dynavax Technologies Quarterly |
| 2022-11-03 | 10Q | DVAX/Dynavax Technologies Quarterly |
| 2022-08-04 | 10Q | DVAX/Dynavax Technologies Quarterly |
Receive DVAX News And Ratings
See the #1 stock for the next 7 days that we like better than DVAX
DVAX Financial Statistics
Sales & Book Value
| Annual Sales: | $232.28M |
|---|---|
| Cash Flow: | $9.93M |
| Price / Cash Flow: | 47.41 |
| Annual Sales: | $4.91 |
| Price / Book: | 2.4 |
Profitability
| EPS (TTM): | 0.11000 |
|---|---|
| Net Income (TTM): | $17.18M |
| Gross Margin: | $182.12M |
| Return on Equity: | 2.8% |
| Return on Assets: | 1.75% |
Dynavax Technologies Earnings Forecast
Key Dynavax Technologies Financial Ratios
- The Gross Profit Margin over the past 19 years for DVAX is 78.40%.
- The Selling, General & Administrative Expenses for DVAX have been equal to 65.84% of Gross Profit Margin.
- The Research & Development expenses have been 23.63% of Revenue.
- The Interest Expense is -105.76% of Operating Income.
- The Net Earning history of DVAX is -2.75% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 17 years.
Dynavax Technologies Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DVAX |
| CUSIP: | 268158 |
| Website: | dynavax.com |
Debt
| Debt-to-Equity Ratio: | 0.35 |
|---|---|
| Current Ratio: | 14.18 |
| Quick Ratio: | 12.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 39.3 |
DVAX Technical Analysis vs Fundamental Analysis
Buy
63
Dynavax Technologies (DVAX)
is a Buy
Is Dynavax Technologies a Buy or a Sell?
-
Dynavax Technologies stock is rated a Buy
The current Dynavax Technologies [DVAX] share price is $11.79. The Score for DVAX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.